Not finding it? Sign in to also search OpenAlex live.
-
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
Mariana Brandão, Elena Prisciandaro, Eleni Xenophontos, Alessio Vincenzo Mariolo, Amir H. Sadeghi, Andrea Riccardo Filippi, +45 more
11citations -
Two-year survival and disease recurrence after endosonography with or without confirmatory mediastinoscopy for resectable lung cancer (a short communication of the MEDIASTrial follow-up)
Jelle E. Bousema, Louisa N. Spaans, Marcel G. W. Dijkgraaf, Erik H.F.M. van der Heijden, Ad F. T. M. Verhagen, Jouke Tabe Annema, +5 more
3citations -
Patients’ Preferences Regarding Invasive Mediastinal Nodal Staging of Resectable Lung Cancer2021 Patient Preference and Adherence article Medicine Lung Cancer Diagnosis and Treatment Open access
Jelle E. Bousema, Fieke Hoeijmakers, Marcel G. W. Dijkgraaf, Jouke Tabe Annema, Frank J.C. van den Broek, M. Elske van den Akker‐van Marle
4citations -
Validation of a Text-Mining Tool for Extracting Routine Clinical Care Data in Early-Stage Resectable Non–Small Cell Lung Cancer2026 JCO Clinical Cancer Informatics article Biochemistry, Genetics and Molecular Biology Biomedical Text Mining and Ontologies
Hanieh Abedian Kalkhoran, Tobias Martinot, Lydia Henrike Nicole Schonewille, Melek Hüyük, Michiel H.J. Huigen, Henk‐Jan Guchelaar, +3 more
0citations -
Surgical audience focused on multimodality treatment for lung cancer2025 Interdisciplinary CardioVascular and Thoracic Surgery editorial Medicine Lung Cancer Diagnosis and Treatment Open access
Francesca Rita Ogliari, Sarah Debakker, Tom van Zwieten, Koen Johan Hartemink, Jonas Willmann, Lizza E.L. Hendriks
0citations -
119MO Phase I/II trial evaluating the innovative therapeutic cancer vaccine PDC*lung01 in combination with anti-PD-1 in patients (pts) with untreated stage IV non-small cell lung cancer2024 Immuno-Oncology Technology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
J.F. Vansteenkiste, Kristof Cuppens, I. Demedts, F. Borm, B. Biesma, Maurice Pérol, +13 more
0citations -
A nationwide population-based cohort study of surgical care for patients with superior sulcus tumors: Results from the Dutch Lung Cancer Audit for Surgery (DLCA-S)
Jacobus A. Winkelman, Lisa van der Woude, David Jonathan Heineman, Idris Bahce, Ronald A.M. Damhuis, Edris A.F. Mahtab, +7 more
6citations -
Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery2020 European Journal of Cardio-Thoracic Surgery article Medicine Lung Cancer Diagnosis and Treatment Open access
Martijn Geert ten Berge, Naomi Beck, Willem Hans Steup, Ad F. T. M. Verhagen, Thomas J. van Brakel, W. H. Schreurs, +1 more
65citations -
Surgical treatment of pulmonary metastases in the Netherlands: data from the Dutch Lung Cancer Audit for Surgery2020 European Journal of Cardio-Thoracic Surgery article Medicine Lung Cancer Diagnosis and Treatment Open access
Martijn van Dorp, Naomi Beck, Willem Hans Steup, Wilhelmina Hendrika Schreurs
34citations -
Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy
Liesbeth M. Hondelink, Sophie M. Ernst, Peggy N. Atmodimedjo, Danielle B. Cohen, Janina L Wolf, Anne‐Marie C. Dingemans, +2 more
33citations -
Variation in incidence, prevention and treatment of persistent air leak after lung cancer surgery2021 European Journal of Cardio-Thoracic Surgery article Medicine Lung Cancer Diagnosis and Treatment Open access
Fieke Hoeijmakers, Koen Johan Hartemink, Ad F. T. M. Verhagen, Willem Hans Steup, Elske Marra, David Jonathan Heineman, +3 more
35citations -
KEYMAKER-U01J: Calderasib plus pembrolizumab with or without cetuximab as first-line treatment for advanced or metastatic nonsquamous non–small-cell lung cancer (NSCLC) with KRAS G12C mutations.2026 Journal of Clinical Oncology conference-abstract Medicine Lung Cancer Treatments and Mutations Open access
Qing Zhou, Daniel Almquist, B K Cho, Egbert Frederik Smit, Christian Caglevic, Ilkka Liikanen, +13 more
0citations -
Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer
Julianne Cynthia de Ruiter, Adrianus Johannes De Langen, Kim Monkhorst, Alexander Veenhof, Houke M. Klomp, Jasper Smit, +3 more
3citations -
The impact of a pathologist’s personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer
Rogier Butter, Liesbeth M. Hondelink, Lisette van Elswijk, Johannes L.G. Blaauwgeers, Elisabeth Bloemena, Rieneke Britstra, +15 more
33citations